Tuesday, June 9, 2009

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ... - SYS-CON Media (press release)

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ... - SYS-CON Media (press release)

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ...
SYS-CON Media (press release), NJ
Patients with greater than three percent Body Surface Area (BSA) psoriasis skin involvement at baseline (n=296) were evaluated for Psoriatic Area and Severity Index (PASI) responses. Of the 296 patients who had at least three percent BSA involved with ...

Source: news.google.com

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ... - SYS-CON Media (press release)

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab ...
SYS-CON Media (press release), NJ
Patients with greater than three percent Body Surface Area (BSA) psoriasis skin involvement at baseline (n=296) were evaluated for Psoriatic Area and Severity Index (PASI) responses. Of the 296 patients who had at least three percent BSA involved with ...

Source: news.google.com